X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (276) 276
index medicus (253) 253
humans (252) 252
established tumors (223) 223
immunology (215) 215
mice (207) 207
oncology (203) 203
immunotherapy (199) 199
cancer (153) 153
in-vivo (148) 148
female (127) 127
mice, inbred c57bl (112) 112
article (105) 105
established melanoma (104) 104
dendritic cells (100) 100
melanoma (98) 98
medicine, research & experimental (93) 93
lymphocytes (87) 87
t cells (87) 87
tumors (87) 87
metastatic melanoma (85) 85
neoplasms - immunology (84) 84
cd4-positive t-lymphocytes - immunology (83) 83
antitumor immunity (77) 77
neoplasms - therapy (76) 76
cell line, tumor (74) 74
cd8-positive t-lymphocytes - immunology (72) 72
adoptive immunotherapy (67) 67
male (67) 67
established pulmonary metastases (66) 66
antigens, neoplasm - immunology (61) 61
care and treatment (56) 56
immunotherapy - methods (56) 56
antigen (54) 54
cancer vaccines - immunology (53) 53
melanoma, experimental - immunology (53) 53
antigens (52) 52
mice, inbred balb c (52) 52
mice, transgenic (51) 51
tumor-infiltrating lymphocytes (50) 50
research (49) 49
t-lymphocytes - immunology (49) 49
cytokines (45) 45
health aspects (45) 45
dendritic cells - immunology (43) 43
expression (43) 43
large established melanoma (43) 43
lymphocytes t (43) 43
melanoma, experimental - therapy (43) 43
t-lymphocytes, cytotoxic - immunology (43) 43
cancer vaccines (42) 42
immunity (42) 42
melanoma - immunology (42) 42
t-cells (42) 42
cell biology (40) 40
adoptive transfer (37) 37
biotechnology & applied microbiology (37) 37
therapy (37) 37
immune response (36) 36
mice, knockout (36) 36
regulatory t-cells (36) 36
cancer-immunotherapy (34) 34
melanoma - therapy (34) 34
t-lymphocytes, regulatory - immunology (34) 34
flow cytometry (33) 33
research article (33) 33
adult (32) 32
genetic aspects (32) 32
ifn-gamma (32) 32
lymphocytes, tumor-infiltrating - immunology (32) 32
cd8 t-cells (31) 31
combined modality therapy (30) 30
cytotoxicity (30) 30
immunotherapy, adoptive (30) 30
immunotherapy, adoptive - methods (30) 30
t cell receptors (30) 30
vaccines (30) 30
abridged index medicus (29) 29
disease models, animal (29) 29
genetics & heredity (29) 29
middle aged (29) 29
cd4 t-cells (28) 28
colony-stimulating factor (28) 28
vaccination (28) 28
analysis (27) 27
gene expression (27) 27
gene therapy (27) 27
lymphocyte activation (27) 27
medicine (27) 27
metastasis (27) 27
review (27) 27
treatment outcome (27) 27
chemical and pharmacologic phenomena (26) 26
interleukin-2 (26) 26
neoplasms - pathology (26) 26
tumor cells, cultured (26) 26
cell proliferation (25) 25
immune-responses (25) 25
melanoma, experimental - pathology (25) 25
multidisciplinary sciences (25) 25
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Immunology, ISSN 0022-1767, 05/2013, Volume 190, Issue 9, pp. 4899 - 4909
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 2013, Volume 210, Issue 9, pp. 1695 - 1710
Treatment with monoclonal antibody specific for cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), an inhibitory receptor expressed by T lymphocytes, has... 
EFFECTOR | MEDICINE, RESEARCH & EXPERIMENTAL | CTLA-4 BLOCKADE | LYMPHOCYTE-ASSOCIATED ANTIGEN-4 | CANCER-PATIENTS | IN-VIVO | COMBINATION IMMUNOTHERAPY | MONOCLONAL-ANTIBODY | IMMUNOLOGY | LARGE ESTABLISHED MELANOMA | GAMMA-RIV | ANTITUMOR-ACTIVITY | Fas Ligand Protein - metabolism | Lymph Nodes - pathology | Antibodies, Blocking - pharmacology | Lymphocyte Depletion | Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use | Receptors, IgG - metabolism | T-Lymphocytes, Regulatory - immunology | Signal Transduction - immunology | Melanoma - prevention & control | Lymph Nodes - drug effects | Cell Membrane - metabolism | Clone Cells | Cell Membrane - drug effects | Tumor Microenvironment - drug effects | Phagocytes - drug effects | Mice, Inbred C57BL | Treatment Outcome | Lymph Nodes - immunology | Lymphocytes, Tumor-Infiltrating - drug effects | Melanoma - pathology | Phagocytes - immunology | TNF-Related Apoptosis-Inducing Ligand - metabolism | Tumor Microenvironment - immunology | T-Lymphocytes, Regulatory - drug effects | Animals | Lymphocytes, Tumor-Infiltrating - pathology | Signal Transduction - drug effects | Melanoma - immunology | CD8-Positive T-Lymphocytes - drug effects | Antibodies, Blocking - therapeutic use | Lymphocyte Count | Mice | CD11b Antigen - metabolism | CD8-Positive T-Lymphocytes - immunology | CTLA-4 Antigen - antagonists & inhibitors | Melanoma - therapy | CD4 Antigens - metabolism | Lymphocytes, Tumor-Infiltrating - immunology
Journal Article
Nature Medicine, ISSN 1078-8956, 08/2012, Volume 18, Issue 8, pp. 1248 - 1253
Interleukin-9 (IL-9) is a T cell cytokine that acts through a gamma C-family receptor on target cells and is associated with inflammation and allergy. We... 
MEDICINE, RESEARCH & EXPERIMENTAL | TGF-BETA | ANTITUMOR RESPONSES | IFN-GAMMA | BIOCHEMISTRY & MOLECULAR BIOLOGY | LARGE ESTABLISHED MELANOMA | CELL BIOLOGY | T(H)17 CELLS | IL-9 PRODUCTION | IN-VIVO | ROR-GAMMA | GROWTH | DIFFERENTIATION | T-Lymphocyte Subsets - immunology | Humans | Neoplasm Proteins - physiology | Receptors, Interleukin - deficiency | Vaccination | Carcinoma, Lewis Lung - immunology | Recombinant Fusion Proteins - physiology | Skin Neoplasms - chemistry | Gene Expression Profiling | Interleukin-9 - physiology | Interleukin-9 - biosynthesis | Melanoma, Experimental - immunology | Cancer Vaccines | Nuclear Receptor Subfamily 1, Group F, Member 3 - deficiency | Neoplasm Proteins - genetics | Melanoma - chemistry | Nuclear Receptor Subfamily 1, Group F, Member 3 - genetics | Interleukin-9 - analysis | Skin - immunology | Skin Neoplasms - pathology | Mast Cells - immunology | Immunotherapy, Adoptive | Skin Neoplasms - immunology | Neoplasm Proteins - biosynthesis | Melanoma, Experimental - therapy | Mice, Inbred C57BL | Melanoma, Experimental - pathology | Lymphatic Metastasis | Radiation Chimera | Melanoma - pathology | Tumor Burden | Mast Cells - drug effects | Receptors, Interleukin - genetics | Disease Progression | Homeodomain Proteins - genetics | Melanoma - secondary | Mice, Knockout | Animals | Interleukin-9 - genetics | Melanoma - immunology | T-Lymphocyte Subsets - metabolism | Carcinoma, Lewis Lung - pathology | Neoplasm Proteins - analysis | Mice | Lymphocytes, Tumor-Infiltrating - immunology | Care and treatment | Melanoma | Interleukin-9 | Genetic aspects | Cellular immunity | Research | Diagnosis | T cells | Health aspects | Metastasis | Cytokines | Gene expression | Lymphocytes | Skin cancer | Immune system
Journal Article
Journal of Immunology, ISSN 0022-1767, 05/2018, Volume 200, Issue 9, pp. 3304 - 3311
Journal Article
JOURNAL OF CLINICAL INVESTIGATION, ISSN 0021-9738, 03/2013, Volume 123, Issue 3, pp. 1371 - 1381
The BRAF mutant, BRAF(V600E), is expressed in nearly half of melanomas, and oral BRAF inhibitors induce substantial tumor regression in patients with... 
MEDICINE, RESEARCH & EXPERIMENTAL | METASTATIC MELANOMA | THERAPY | RESISTANCE | TUMOR-ASSOCIATED MACROPHAGES | ANTIBODY | MICE | CANCER-IMMUNOTHERAPY | ANTITUMOR IMMUNITY | ESTABLISHED TUMORS | BRAF(V600E) | Care and treatment | Immunotherapy | Melanoma | Physiological aspects | Genetic aspects | Research | Chemokine receptors
Journal Article
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 03/2015, Volume 64, Issue 4, pp. 507 - 518
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2010, Volume 107, Issue 34, pp. 15187 - 15192
Journal Article